Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > DC Providers

Dr. Harminder S. Sethi, MD

Accepting New Patients

(Dr. Harminder Singh Sethi, MD)

(No ratings)

Specializes in: Medical Oncology, Adult Oncology and Adult Hematology

Indira Gandhi Medical College (1991)

Professional interests include: bleeding disorders, thrombophilia (clotting disorders), radiation therapy, and more.

1160 Varnum Street Nw Suite 302
Washington, DC 20017

(202) 636-9090

Dr. Harminder S. Sethi, MD is a medical oncologist in Washington, DC specializing in medical oncology, adult oncology and adult hematology. He graduated from Indira Gandhi Medical College in 1991 and has 35 years of experience. Dr. Harminder S. Sethi, MD is affiliated with Holy Cross Health, MedStar Washington Hospital Center, MedStar Health and MARYLAND ONCOLOGY HEMATOLOGY PA.

Office Locations

110 Irving Street Nw
Washington, DC 20010

open_in_new

Holy Cross Health

1160 Varnum Street Nw Suite 302
Washington, DC 20017

(202) 636-9090

open_in_new

Holy Cross Health

6505 Belcrest Road Suite 110
Hyattsville, MD 20782

(301) 779-8800

open_in_new

Some issues Dr. Harminder S. Sethi, MD can help you with:

Anemia

Anemia is the most common blood disorder. It occurs when the body does not have enough red blood cells to carry oxygen to the tissues. Blood loss, insufficient red blood cell production, and red blood cell destruction are the three main causes of anemia. These issues may arise from such conditions as iron deficiency, heavy periods, ulcers, kidney disease, as well as some forms of cancer.

An individual with anemia will have the following symptoms: shortness of breath, weakness, dizziness, cold hands or feet, paleness, and irritability. Anemia is diagnosed when blood tests show low counts for hemoglobin, which is the protein responsible for carrying oxygen to different tissues throughout the body.

Treatments for anemia are dependent on the kind of anemia an individual has. For example, iron supplementation may correct iron deficiency anemia. For anemia caused by chronic kidney failure, chemotherapy treatments, and HIV/AIDS, a group of medications called erythropoiesis-stimulating agents may be prescribed.

Blood Transfusion

Blood transfusions typically treat those who experience a substantial loss of blood from an injury or surgical procedure, or those who suffer from conditions that alter the blood supply or blood components. For example, a blood transfusion may contribute additional red blood cells to someone with anemia, a condition where the body does not produce enough red blood cells. Other conditions may include:

Hemophilia (blood clotting disorder)
Leukemia
Liver disease
Sickle cell disease (misshapen red blood cells)
Thrombocytopenia (lack of platelets)

When a patient has sufficient blood volume and lacks one or more components, a complete blood count (CBC) test can help determine if a patient requires a transfusion by measuring four blood components: red blood cells, white blood cells, platelets, and hemoglobin. If any of the patient's component counts is significantly below a standard range, the patient will likely need a blood transfusion. The complete blood count test uses a needle to extract a small amount of blood for testing.

Blood transfusion recipients should be tested for their blood type, which is one of four different types: type A, B, AB, or O. Patients with A, B, and O blood can only receive a blood donation matching their blood type or of O blood, which is known as the universal donor. Those with AB blood are considered "universal recipients"; they may receive A, B, AB, or O blood. Further complicating blood types is the presence or absence of the RhD antigen, adding a positive or negative modifier that should also be considered. Incompatible blood donations may cause transfusion sickness, such as a hemolytic reaction, where the body fights the donated red blood cells.

In certain emergency or trauma situations, medical teams often do not perform a complete blood count (CBC) test or blood type test. In those cases, patients are often given O negative blood, which is universally accepted. Some patients have their blood type on a medical card or bracelet, allowing emergency medical teams to issue compatible blood without testing.

Transfusions are performed by inserting a needle attached to an intravenous line (IV) into a vein in the body. This IV line is attached to a bag of blood that steadily dispenses blood into the patient's bloodstream. The type, volume, and components of donated blood depend on the patient's condition and needs. After the transfusion is complete, patients are generally permitted to resume normal activity, unless prohibited by a condition or injury. Some patients may experience bruising or soreness around the area that the needle was inserted.

At times, a second complete blood count test is performed to determine if the transfusion has brought patients' component counts to normal levels. Some patients may require multiple blood transfusions to reach a healthy blood volume and blood component count.

Once patients' blood volumes and components reach sufficient levels, they will generally begin to feel better. Patients of all ages, from newborn infants to elderly adults, can receive a blood transfusion.

Hemophilia

Hemophilia is a bleeding disorder in which blood cannot clot normally. After an injury, people who have hemophilia bleed longer because they lack certain blood proteins that are responsible for clotting, called clotting factors. Some hemophiliacs are mildly deficient in this protein, so they bleed only when injured or after surgery. Those who are severely deficient, however, may experience symptoms of spontaneous bleeding, including the following:

Presence of blood in stool or urine
Frequent nosebleeds or large bruises
Unusual bleeding after being vaccinated
Pain, swelling, or tightness in joint

Most people with hemophilia have a family history of the disorder, though about 30% do not. The most common forms are hemophilia A (classic hemophilia) and hemophilia B (Christmas disease). Hemophilia A and B share certain characteristics, but different genes are involved. Acquired hemophilia is very rare and has been linked to autoimmune conditions, cancer, and multiple sclerosis.

Hemophilia may be diagnosed using a blood test. If there is family history of the disorder, testing may be done prenatally. Treatment involves regular intravenous replacement of clotting factors, which may be produced in a laboratory (recombinant) or come from blood donors. For people with milder forms of the disease, a hormone called desmopressin may stimulate the body to produce clotting factors. Other drug therapies include medications that help slow the breakdown of blood clots and medications that are applied directly to the wound to promote clotting.

Living with hemophilia can be challenging, but simple things may help prevent excessive bleeding. For example, choosing activities like walking or swimming over contact sports can prevent injuries and strengthen muscles while protecting the joints. Chances for bleeding may also be reduced by making sure that children wear helmets and elbow pads during activities like bicycle rides.

Noteworthy Medicare Patient Procedures Performed by Dr. Harminder S. Sethi, MD in 2023

Click on any procedure below to see further details on volume and pricing among Medicare patients.

Top 5%

By Volume:

serum folate test

By Affordability:

inpatient hospital care

quantitative Ig tests

In 2023, among providers in related specialties within District of Columbia, Dr. Harminder S. Sethi, MD performed more serum folate test procedures for Medicare patients than 95% of them and he also had a list price for folic acid tests, hospital care, IgD test, IgM test, inpatient care, inpatient hospital care (for patient admitted to hospital), quantitative Ig tests, serum folate test, total IgA test, total IgG test, and vitamin B12 test that was lower than the list prices billed to Medicare by 95% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Top 25%

By Volume:

blood tests

intravenous infusion

By Affordability:

In 2012, among providers in related specialties within District of Columbia, Dr. Harminder S. Sethi, MD performed more blood tests, and intravenous (IV) infusion procedures for Medicare patients than 75% of them and he also had a list price for IgA test, IgG test, immunoglobulin tests, intravenous (IV) infusion, and iron tests that was lower than the list prices billed to Medicare by 75% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Medicare Procedure and Patient Information

2012 Medicare Procedure Volume

The top procedures that Dr. Harminder S. Sethi, MD treated as a medical oncologist in Washington, DC during 2012 were blood draw, minimally invasive procedures, chemotherapy and biological response modifier (BRM) therapy.

Volume of procedures performed by Dr. Harminder S. Sethi, MD for Medicare patients.

biological response modifier (BRM) therapy	520
blood draw	952
chemotherapy	520
doctor visit	890
hormone therapy	51
hospital care	403
inpatient care	403
minimally invasive procedures	725
port flush	13

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

The top procedures that Dr. Harminder S. Sethi, MD treated as a medical oncologist in Washington, DC during 2013 were blood draw, minimally invasive procedures, chemotherapy and biological response modifier (BRM) therapy.

Volume of procedures performed by Dr. Harminder S. Sethi, MD for Medicare patients.

biological response modifier (BRM) therapy	392
blood draw	1064
chemotherapy	392
doctor visit	1019
hormone therapy	104
hospital care	223
inpatient care	223
minimally invasive procedures	599
port flush	88

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. Harminder S. Sethi, MD.

**Gender**
Male	143
Female	285

**Ethnicity**
Non-Hispanic White	22
Black	387
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	159
From 75 to 84	137
85 and over	59
Less than 65	73

Conditions of Medicare patients treated by Dr. Harminder S. Sethi, MD in 2013

Hypertension	75
High Cholesterol	60
Stroke	9
Ischemic Heart Disease	40
Depression	12
Chronic Kidney Disease	46
Asthma	12
Osteoperosis	12
Atrial Fibrilation	7
Heart Failure	32
Chronic Obstructive Pulmonary Disease	19
Diabetes	49
Dementia	20
Cancer	46

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

The top procedures that Dr. Harminder S. Sethi, MD treated as a medical oncologist in Washington, DC during 2014 were blood draw, minimally invasive procedures, chemotherapy and biological response modifier (BRM) therapy.

Volume of procedures performed by Dr. Harminder S. Sethi, MD for Medicare patients.

aspiration	13
biological response modifier (BRM) therapy	407
blood draw	1050
bone marrow tests	26
chemotherapy	407
diagnostic procedures	13
doctor visit	933
hospital care	54
inpatient care	54
minimally invasive procedures	706
port flush	101

2014 Medicare Patient Data

Information about Medicare patients treated by Dr. Harminder S. Sethi, MD.

**Gender**
Male	125
Female	283

**Ethnicity**
Non-Hispanic White	0
Black	368
Hispanic	17
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	144
From 75 to 84	133
85 and over	59
Less than 65	72

Conditions of Medicare patients treated by Dr. Harminder S. Sethi, MD in 2014

Hypertension	75
High Cholesterol	57
Stroke	8
Ischemic Heart Disease	32
Depression	11
Chronic Kidney Disease	37
Asthma	13
Osteoperosis	11
Atrial Fibrilation	4
Heart Failure	23
Chronic Obstructive Pulmonary Disease	13
Diabetes	49
Dementia	15
Cancer	51

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

The top procedures that Dr. Harminder S. Sethi, MD treated as a medical oncologist in Washington, DC during 2015 were blood draw, minimally invasive procedures, chemotherapy and biological response modifier (BRM) therapy.

Volume of procedures performed by Dr. Harminder S. Sethi, MD for Medicare patients.

aspiration	12
biological response modifier (BRM) therapy	523
blood draw	1241
bone marrow tests	24
chemotherapy	523
diagnostic procedures	12
doctor visit	1101
hormone therapy	48
hospital care	98
inpatient care	98
minimally invasive procedures	866
port flush	105

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. Harminder S. Sethi, MD.

**Gender**
Male	306
Female	620

**Ethnicity**
Non-Hispanic White	0
Black	848
Hispanic	36
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	358
From 75 to 84	250
85 and over	130
Less than 65	188

Conditions of Medicare patients treated by Dr. Harminder S. Sethi, MD in 2015

Hypertension	75
High Cholesterol	56
Stroke	12
Ischemic Heart Disease	37
Depression	15
Chronic Kidney Disease	40
Asthma	17
Osteoperosis	6
Atrial Fibrilation	7
Heart Failure	27
Chronic Obstructive Pulmonary Disease	19
Diabetes	52
Dementia	20
Cancer	47

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

The top procedures that Dr. Harminder S. Sethi, MD treated as a medical oncologist in Washington, DC during 2016 were blood draw, lab tests, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Harminder S. Sethi, MD for Medicare patients.

biological response modifier (BRM) therapy	414
blood draw	1348
chemotherapy	414
doctor visit	1003
hormone therapy	100
lab tests	1151
minimally invasive procedures	794
port flush	73

2016 Medicare Patient Data

Information about Medicare patients treated by Dr. Harminder S. Sethi, MD.

**Gender**
Male	129
Female	277

**Ethnicity**
Non-Hispanic White	14
Black	371
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	159
From 75 to 84	120
85 and over	51
Less than 65	76

Conditions of Medicare patients treated by Dr. Harminder S. Sethi, MD in 2016

Hypertension	75
High Cholesterol	49
Stroke	5
Ischemic Heart Disease	36
Depression	11
Chronic Kidney Disease	42
Asthma	23
Osteoperosis	8
Atrial Fibrilation	4
Heart Failure	23
Chronic Obstructive Pulmonary Disease	17
Diabetes	48
Dementia	14
Cancer	52

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

The top procedures that Dr. Harminder S. Sethi, MD treated as a medical oncologist in Washington, DC during 2017 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Harminder S. Sethi, MD for Medicare patients.

biological response modifier (BRM) therapy	342
blood draw	1359
chemotherapy	342
doctor visit	1109
hormone therapy	142
lab tests	2329
minimally invasive procedures	551
port flush	41

2017 Medicare Patient Data

Information about Medicare patients treated by Dr. Harminder S. Sethi, MD.

**Gender**
Male	124
Female	293

**Ethnicity**
Non-Hispanic White	15
Black	379
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	172
From 75 to 84	116
85 and over	51
Less than 65	78

Conditions of Medicare patients treated by Dr. Harminder S. Sethi, MD in 2017

Hypertension	75
High Cholesterol	43
Stroke	6
Ischemic Heart Disease	33
Depression	15
Chronic Kidney Disease	39
Asthma	12
Osteoperosis	6
Atrial Fibrilation	4
Heart Failure	22
Chronic Obstructive Pulmonary Disease	16
Diabetes	47
Dementia	14
Cancer	49

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

The top procedures that Dr. Harminder S. Sethi, MD treated as a medical oncologist in Washington, DC during 2018 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Harminder S. Sethi, MD for Medicare patients.

biological response modifier (BRM) therapy	287
blood draw	1157
chemotherapy	287
doctor visit	1075
hormone therapy	93
lab tests	2163
minimally invasive procedures	466
port flush	50

2018 Medicare Patient Data

Information about Medicare patients treated by Dr. Harminder S. Sethi, MD.

**Gender**
Male	109
Female	308

**Ethnicity**
Non-Hispanic White	16
Black	380
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	156
From 75 to 84	130
85 and over	57
Less than 65	74

Conditions of Medicare patients treated by Dr. Harminder S. Sethi, MD in 2018

Hypertension	75
High Cholesterol	56
Stroke	4
Ischemic Heart Disease	35
Depression	15
Chronic Kidney Disease	36
Asthma	11
Osteoperosis	8
Atrial Fibrilation	4
Heart Failure	21
Chronic Obstructive Pulmonary Disease	16
Diabetes	48
Dementia	18
Cancer	47

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

The top procedures that Dr. Harminder S. Sethi, MD treated as a medical oncologist in Washington, DC during 2019 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Harminder S. Sethi, MD for Medicare patients.

biological response modifier (BRM) therapy	241
blood draw	1046
chemotherapy	241
doctor visit	891
hormone therapy	76
lab tests	1708
minimally invasive procedures	461
port flush	44

2019 Medicare Patient Data

Information about Medicare patients treated by Dr. Harminder S. Sethi, MD.

**Gender**
Male	100
Female	277

**Ethnicity**
Non-Hispanic White	12
Black	346
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	149
From 75 to 84	114
85 and over	54
Less than 65	60

Conditions of Medicare patients treated by Dr. Harminder S. Sethi, MD in 2019

Hypertension	75
High Cholesterol	54
Stroke	6
Ischemic Heart Disease	32
Depression	15
Chronic Kidney Disease	42
Asthma	10
Osteoperosis	11
Atrial Fibrilation	6
Heart Failure	23
Chronic Obstructive Pulmonary Disease	14
Diabetes	47
Dementia	15
Cancer	48

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

The top procedures that Dr. Harminder S. Sethi, MD treated as a medical oncologist in Washington, DC during 2020 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Harminder S. Sethi, MD for Medicare patients.

biological response modifier (BRM) therapy	141
blood draw	813
chemotherapy	141
doctor visit	982
hormone therapy	107
lab tests	1697
minimally invasive procedures	300

2020 Medicare Patient Data

Information about Medicare patients treated by Dr. Harminder S. Sethi, MD.

**Gender**
Male	125
Female	299

**Ethnicity**
Non-Hispanic White	16
Black	389
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	151
From 75 to 84	141
85 and over	72
Less than 65	60

Conditions of Medicare patients treated by Dr. Harminder S. Sethi, MD in 2020

Hypertension	75
High Cholesterol	57
Stroke	7
Ischemic Heart Disease	34
Depression	13
Chronic Kidney Disease	44
Asthma	10
Osteoperosis	13
Atrial Fibrilation	5
Heart Failure	23
Chronic Obstructive Pulmonary Disease	13
Diabetes	47
Dementia	16
Cancer	47

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

The top procedures that Dr. Harminder S. Sethi, MD treated as a medical oncologist in Washington, DC during 2021 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Harminder S. Sethi, MD for Medicare patients.

biological response modifier (BRM) therapy	309
blood draw	1261
chemotherapy	309
doctor visit	1329
lab tests	3476
minimally invasive procedures	523

2021 Medicare Patient Data

Information about Medicare patients treated by Dr. Harminder S. Sethi, MD.

**Gender**
Male	100
Female	302

**Ethnicity**
Non-Hispanic White	13
Black	366
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	154
From 75 to 84	130
85 and over	69
Less than 65	49

Conditions of Medicare patients treated by Dr. Harminder S. Sethi, MD in 2021

Hypertension	75
High Cholesterol	60
Stroke	5
Ischemic Heart Disease	31
Depression	12
Chronic Kidney Disease	43
Asthma	7
Osteoperosis	17
Atrial Fibrilation	4
Heart Failure	20
Chronic Obstructive Pulmonary Disease	12
Diabetes	45
Dementia	13
Cancer	44

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

The top procedures that Dr. Harminder S. Sethi, MD treated as a medical oncologist in Washington, DC during 2022 were lab tests, minimally invasive procedures, blood draw and chemotherapy.

Volume of procedures performed by Dr. Harminder S. Sethi, MD for Medicare patients.

biological response modifier (BRM) therapy	155
blood draw	281
chemotherapy	155
doctor visit	1045
lab tests	2275
minimally invasive procedures	287
thyroid function tests	17

2022 Medicare Patient Data

Information about Medicare patients treated by Dr. Harminder S. Sethi, MD.

**Gender**
Male	104
Female	270

**Ethnicity**
Non-Hispanic White	14
Black	332
Hispanic	13
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	130
From 75 to 84	130
85 and over	64
Less than 65	50

Conditions of Medicare patients treated by Dr. Harminder S. Sethi, MD in 2022

Hypertension	75
High Cholesterol	74
Stroke	9
Ischemic Heart Disease	20
Depression	11
Chronic Kidney Disease	38
Asthma	13
Osteoperosis	25
Atrial Fibrilation	13
Heart Failure	16
Chronic Obstructive Pulmonary Disease	16
Diabetes	46
Dementia	8
Cancer	45

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2012 - 2022

Volume of procedures performed by Dr. Harminder S. Sethi, MD for Medicare patients.

The highest averages for the top procedures that Dr. Harminder S. Sethi, MD treated as a medical oncologist in Washington, DC were lab tests, blood draw, minimally invasive procedures and chemotherapy.

aspiration	12
biological response modifier (BRM) therapy	339
blood draw	1052
bone marrow tests	25
chemotherapy	339
diagnostic procedures	12
doctor visit	1034
hormone therapy	90
hospital care	194
inpatient care	194
lab tests	2114
minimally invasive procedures	570
thyroid function tests	17

Average Medicare Patient Data From 2012 - 2022

Information about Medicare patients treated by Dr. Harminder S. Sethi, MD.

**Gender**
Male	124
Female	292

**Ethnicity**
Black / African American	378
Asian / Pacific Islander	0
Non-Hispanic White	11
Native American / Alaskan Native	0
Hispanic	6
Other	0

**Age**
75 to 84	127
85 and over	60
Less than 65	70
65 to 74	157

Average of Total of Conditions of Medicare patients treated by Dr. Harminder S. Sethi, MD From 2012 - 2022

The highest averages of the most common conditions of Medicare patients that Dr. Harminder S. Sethi, MD treated were hypertension, high cholesterol, cancer and diabetes.

Hypertension	68
High Cholesterol	51
Stroke	6
Ischemic Heart Disease	30
Depression	11
Chronic Kidney Disease	37
Asthma	11
Osteoporosis	10
Heart Failure	20
Chronic Obstructive Pulmonary Disease	14
Diabetes	43
Atrial Fibrillation	5
Dementia	13
Cancer	43

Education & Training

Dr. Harminder S. Sethi, MD graduated from Indira Gandhi Medical College in 1991. He completed residency at North Shore University Hospital. He is certified by the American Board of Internal Medicine, Hematology and has a state license in Maryland.

Medical School: Indira Gandhi Medical College (1991)

Residency: North Shore University Hospital (1996)

Board Certification: American Board of Internal Medicine, Hematology

Licensed In: Maryland

Affiliations & Hospitals

Dr. Harminder S. Sethi, MD is associated with these hospitals and organizations:

Holy Cross Health

MedStar Washington Hospital Center

MedStar Health

MARYLAND ONCOLOGY HEMATOLOGY PA

Ratings & Reviews

Dr. Harminder S. Sethi, MD does not have any reviews yet, be the first to leave a review of Dr. Harminder S. Sethi, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Harminder S. Sethi, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Janssen Biotech, Inc.	$678 IMBRUVICA $167	DARZALEX $89	Erleada $81	RYBREVANT $60	TECVAYLI $46	Other $235
Novartis Pharmaceuticals Corporation	$418 KISQALI $101	PIQRAY $36	Lutathera $29	PLUVICTO $25	TASIGNA $23	Other $205
Daiichi Sankyo Inc.	$408 Enhertu $218	Injectafer $190
EISAI INC.	$373 Halaven $225	Lenvima $148
AstraZeneca Pharmaceuticals LP	$363 CALQUENCE $121	IMFINZI $89	LYNPARZA $79	Enhertu $21	$53
Other	$5,115 IMBRUVICA $264	OPDIVO $163	LIBTAYO $149	XTANDI $132	KEYTRUDA $126	Other $4,280

**Types of Payments**
Food and Beverage	$6,506
Education	$400
Honoraria	$250
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$200

Biography

Dr. Harminder Sethi's specialties are adult hematology, adult oncology, and medical oncology. Clinical interests for Dr. Sethi include vitamin deficiencies, leukopenia, and aspiration. Dr. Sethi's professional affiliations include Holy Cross Health and MedStar Washington Hospital Center. According to Holy Cross Health, new patients are welcome to contact his office in Hyattsville, MD. Dr. Sethi studied medicine at Indira Gandhi Medical College. His residency was performed at North Shore University Hospital and Forest Hills Hospital. Dr. Sethi (or staff) speaks Hindi and Punjabi.